Shauna Levy, a specialist in obesity medicine and the medical director of the Tulane Bariatric Center in New Orleans, are "mind-blowing." Levy, who was not involved with the research, said the drug seems to be delivering results that are approaching the effectiveness of bariatric surgery
Whats the difference between Melanotan-I, Melanotan-II, and PT-141
Your First Step Consultation and Preparation Starting with a personalized consultation, our team will review your medical history, current health conditions, and previous weight loss efforts
Semaglutide, marketed as Ozempic (for diabetes) and Wegovy (for weight management), is a GLP-1 receptor agonist that has been approved by the FDA for both type 2 diabetes and chronic weight management